Global Skin Disinfectants Market Research Report 2022

Antiseptics are chemical agents that slow or stop the growth of micro-organisms on external body surfaces, helping prevent infections.
Due to the COVID-19 pandemic, the global Skin Disinfectants market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Skin Disinfectants market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Skin Disinfectants landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Alcohols accounting for % of the Skin Disinfectants global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Surgeries segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Skin Disinfectants include 3M, BD, Johnson & Johnson Services, Reckitt Benckiser, B. Braun Melsungen, Purdue Pharma, EcoLab, Schülke & Mayr GmbH and PSK Pharma, etc. In terms of revenue, the global 3 largest players have a % market share of Skin Disinfectants in 2021.
This report focuses on Skin Disinfectants volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Skin Disinfectants market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Skin Disinfectants Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Alcohols
Chlorhexidine
Iodine
Octenidine
Others
Segment by Application
Surgeries
Injections
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
3M
BD
Johnson & Johnson Services
Reckitt Benckiser
B. Braun Melsungen
Purdue Pharma
EcoLab
Schülke & Mayr GmbH
PSK Pharma
Kimberly-Clark
Sirmaxo Chemicals
Avrio Health
Sage Products LLC
Walgreen Co.
CVS Health
Mölnlycke Health Care
MPM Medical, Inc.
Lagaay International
Cardinal Health
Smith & Nephew
Microgen